Cue Biopharma, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CUE | EDSA | CMPX | CHRS | HBP.TO | VRXA | |
|---|---|---|---|---|---|---|
| Market cap | 144.13M | 29.32M | 137.35M | 131.36M | 70.27M | 134.34M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -41.3 | — | -1.4 | -1.3 | -8.4 | — |
| Price/book | 44.9 | 52.9 | 0.8 | 2.2 | 4.8 | -0.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −5.14% | +27.65% | −80.29% | −42.95% | −54.68% | −90.96% |
| Today | −4.89% | −4.82% | +1.29% | +5.54% | 0.00% | −4.04% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CUE news ›Onesource Specialty Pharma announces change in designation for Dr. Claudio Albrecht
Onesource Specialty Pharma Ltd changes Dr. Claudio Albrecht's role from Independent Director to Non-Executive Non-Independent Director. Onesource Specialty Pharma announces change in designation for Dr. Claudio Albrecht Onesource Specialty…
Cue Biopharma (NASDAQ:CUE) Insider Sells $51,724.20 in Stock
Cue Biopharma, Inc. (NASDAQ:CUE – Get Free Report) insider Sumita Ray sold 1,844 shares of the firm’s stock in a transaction on Monday, October 12th. The stock was sold at an average price of $28.05, for a total value of $51,724.20.…
Cue Biopharma: Shao-Lee Lin proposes $305K share sale
Tax withholding prompts a proposed 11,087-share sale by Cue Biopharma (CUE) officer Shao-Lee Lin. Stock Titan Cue Biopharma: Shao-Lee Lin proposes $305K share sale Lin's reported prior sales were 40,000 shares on August 12 and 18,258…
Cue Biopharma: Sumita Ray proposes $51.7K share sale
A non-discretionary $51.7K share sale at Cue Biopharma (CUE) would cover stock-grant taxes. Stock Titan Cue Biopharma: Sumita Ray proposes $51.7K share sale The proposed transaction is described as a non-discretionary sell-to-cover sale…
Cue Biopharma: Mark E. Strome reports 8.5% stake
A 5% warrant ownership cap was raised for a fund reporting a stake in Cue Biopharma (CUE). Stock Titan - [SCHEDULE 13G/A] Cue Biopharma, Inc. Amended Passive Investment Disclosure Cue Biopharma: Mark E. Strome reports 8.5% stake The…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net3
- businessupturn.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.